NeoStem to present VSEL Technology for Battlefield Wounds treatment at USU-HJF Symposium

Sep 23 2010

NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that the Company will be presenting its  Autologous Adult Stem Cell VSEL™ Technology for the Treatment of Battlefield Wounds at The USU-HJF Military Medicine Symposium in Washington DC, September 23rd, 2010.

NeoStem has a worldwide exclusive license to VSEL™ Technology which uses very small embryonic-like stem cells, a heterogeneous population of stem cells found in adult bone marrow that have properties similar to those of embryonic stem cells.  NeoStem has shown that very small embryonic-like stem cells can be mobilized into the peripheral blood, enabling a minimally invasive means for collecting what NeoStem believes to be an important population of stem cells that may have the potential to achieve the positive benefits associated with embryonic stem cells without the ethical or moral dilemmas or the potential negative effects associated with embryonic stem cells.

The Center for Public-Private Partnerships at the Henry M. Jackson Foundation for the Advancement of Military Medicine, along with the USU (Uniformed Services University of the Health Sciences), will present a symposium highlighting important advances in military medicine. The event will bring together a broad spectrum of participants, including representatives of the Military Health System and military leadership, federal agencies, private research institutions, philanthropists and charitable foundations, representatives of industry, and policymakers.

Panels will highlight advancements in research and clinical care, including:

• The state-of-the-science in regenerative medicine technologies and potential applications for wounded warriors
• The latest research on suicide prevention and traumatic stress among military veterans
• Community outreach to address psychological health challenges faced by service members and their families

The event is intended to foster collaboration and expand public-private partnerships to advance military medical research. The program will include opportunities for discussion and networking among participants.

The USU-HJF Military Medicine Symposium will be held on Thursday, September 23, 2010, at the Omni Shoreham Hotel located at 2500 Calvert Street, NW in Washington, DC.  NeoStem will be exhibiting in the Blue Pre-Function Room its presentation on "Autologous Adult Stem Cell Solutions to Battlefield Wounds: Future Prospects for VSEL Technology".  NeoStem's exhibit will be on display throughout the day from 7:30 am to 6:30 pm.